Biobank Aimed to Study Gynecological Pathologies, of Male and Female Infertility and Pregnancy Pathologies
NCT ID: NCT07265908
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
3000 participants
OBSERVATIONAL
2024-04-09
2043-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gynecological Diseases
NCT04698109
Evaluation of Genetic Signature in Endometriosis Disease by Non Invasive Sampling
NCT06100471
The Embryo-endometrium Multifaceted Interface: Endometrial Cavity Molecular Microbiobial and Transcriptomic Signatures in Predictinf Pregnancy Outcome in Infertile Patients Undergoing Assisted Reproduction Technology Procedures
NCT07085585
Metabolomic Profile in Women With and Without Endometriosis
NCT05496218
Next-Generation Endometriosis Diagnostics Through Comprehensive Multi-Dimensional Analysis
NCT06572852
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Affected participants
Subjects diagnosed with gynecological disorders, male or female infertility, or pregnancy-associated conditions.
Blood sampling
Blood sampling
Healthy participants
Subjects without a diagnosis of gynecological disorders, male or female infertility, or pregnancy-associated conditions.
Blood sampling
Blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sampling
Blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female infertility
* Gynecological disorders
* Pregnancy-related conditions
* Conditions requiring fertility preservation treatment (oocyte cryopreservation, ovarian tissue preservation)
* Informed consent signed by the adult patient or by the parents/legal guardians of pediatric patients
* Healthy adult subjects (including pregnant and lactating women)
* Able to give informed consent for participation in the study
Exclusion Criteria
* Patients unable or unwilling to sign the informed consent
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Enrico Papaleo
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enrico Papaleo, MD
Role: PRINCIPAL_INVESTIGATOR
IRCCS San Raffaele
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Irccs San Raffaele Hospital
Milan, Milan, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REPRO-Biobank
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.